Friday 6 November 2026 Export HALO’s income statement to Excel — free account

Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 37.6% from fiscal 2024.

Revenue: +39.2%
EPS: +45.6%
Free cash flow: −58.6%
Total debt: +115.1%

Quarter to September 2026, against a year earlier

103.93 19.03 −15.48%

Follow HALO

Alert me

Market cap: $14.0B
P/E: 29.5×
Fwd P/E: 17.9×
Dividend yield: —
F-score: 5/9
Altman Z: 3.46
Beneish M: −2.59
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26 From the 10-Q filed 5 Nov
Piotroski F-Score Full definition →	+8 more TTM periods Free account	5	5	5	6
ROE Full definition →		153.59%	99.40%	173.67%	216.38%
ROA Full definition →		13.81%	14.33%	17.86%	17.05%
ROIC Full definition →		14.31%	15.64%	18.13%	19.87%
Return on Tangible Assets Full definition →		43.39%	48.31%	61.47%	33.41%
Average Days of Receivables Full definition →		115.33	110.82	100.00	106.43
Free Cash Flow per Share Full definition →		5.38	5.65	6.87	7.89
Free Cash Flow Full definition →		644.59	667.65	806.22	898.27
Capital Expenditures Full definition →		(6.97)	(9.76)	(12.37)	—
Other line items
Cash ROIC Full definition →		27.61%	24.89%	31.98%	21.04%
Accounts Receivable Turnover Full definition →		3.73	3.96	4.31	4.14
Accounts Payable Turnover Full definition →		14.69	15.19	13.83	13.07
Inventory Turnover Full definition →		1.44	1.62	1.84	2.01
Average Days of Payables Full definition →		33.34	19.82	29.47	38.30
Days of Inventory on Hand Full definition →		281.56	218.58	171.17	151.43
Tax Rate Full definition →		(0.32)	(0.31)	(0.29)	(0.26)
Research and Development Expense of Revenue Full definition →		26.23%	25.00%	23.28%	22.07%
Selling, General and Administrative Expense of Revenue Full definition →		14.83%	14.76%	14.30%	13.88%
Share Based Compensation of Revenue Full definition →		3.69%	3.81%	3.79%	3.76%
Interest Coverage Full definition →		25.87	26.79	29.41	30.58
Operating CF/Net income Full definition →		2.06	1.94	1.98	1.85
Depreciation/Fixed assets Full definition →		1.12	1.31	1.45	0.00
Capex/Depreciation Full definition →		(0.08)	(0.09)	(0.10)	—
Revenue per Share Full definition →		11.65	12.77	14.19	15.84
Operating CF per Share Full definition →		5.44	5.73	6.98	7.89
Capex per Share Full definition →		(0.06)	(0.08)	(0.11)	0.00
Capex to Sales Full definition →		0.01	0.01	0.01	0.00

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly